$NXDT

Swain Carol sold (to issuer) 2,415 shares of NXDT

Swain Carol sold (to issuer) 2,415 shares of NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT) on 2026-06-10.

Original reporting
SEC EDGAR · Swain Carol
Published Jun 12, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 10:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NXDT
Neutral
high confidence
Mentioned
$NXDT
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NXDTNeutralLow
01

Why it matters

The newest fact is the reported sale of 2,415 shares to the issuer on 2026-06-10, with holdings after transaction at 28,197 shares.

02

Market read

Traders may note insider activity, but the filing lacks price/value and does not change NXDT fundamentals.

03

What to watch

No sale price or total value is provided, and the absence of a 10b5-1 plan does not, by itself, imply negative expectations without additional context or follow-on filings.

Relevance 3/10Novelty 3/10Timing: filed 2026-06-12, transaction dated 2026-06-10

Background

The article is a SEC Form 4 insider transaction disclosure for NXDT, reported by director Swain Carol.

Company-level read

Ticker impact

$NXDTNeutralHigh confidence
Context

NEXPOINT DIVERSIFIED REAL ESTATE TRUST (NXDT) disclosed a Form 4 showing director Swain Carol sold 2,415 shares to the issuer on 2026-06-10.

Expected impact

Likely limited near-term impact; treat as low-signal unless repeated or tied to other disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with sale price not disclosed and no 10b5-1 plan, but it contains no company-specific operational or financial catalyst.

Market effects

No clear sector read-through from a single director sale to the issuer.

None indicated.

None indicated.

Counterpoint

The sale code indicates a sale to the issuer (often buyback participation), which may be administrative rather than a bearish signal.

Key entities

  • NXDT

    NexPoint Diversified Real Estate Trust, the company that filed the Form 4 insider transaction.

  • Swain Carol

    Director who sold 2,415 shares to the issuer; price not disclosed.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LYCAMedAI 8/10

Venrock Healthcare Capital Partners III, L.P. (Koh Bong Y, Shah Nimish P) purchased $37.7M of LYCA (indirect holdings)

Venrock Healthcare Capital Partners III, L.P. purchased 2,045,440 indirectly-held shares of Lycia Therapeutics, Inc. (LYCA) at an average of $18.41 ($18.00–$26.97, $37.65M total) across 6 trades over 2026-10-23 to 2026-10-27. Filed jointly with VHCP Co-Investment Holdings III, LLC (10% owner), VHCP Management III, LLC (10% owner), Venrock Healthcare Capital Partners EG, L.P. (10% owner), VHCP Management EG, LLC (10% owner), Venrock Healthcare Capital Partners XP, L.P. (10% owner), VHCP Management XP, LLC (10% owner), Koh Bong Y (10% owner) and Shah Nimish P (10% owner).